Influenza a (H7N9) Vaccine Delivered Intradermally by High-density Microarray Patch (HD-MAP)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
Study SP-1219-007 is a multi-centre, randomised, study designed to access the safety and tolerability of two doses of monovalent Influenza A (H7N9) vaccine delivered intradermally by a microarray patch delivery system in healthy adults aged 18 to 50 years.
Epistemonikos ID: fcfc13c45bc221da374efcf0d93f4e6e4fe2135c
First added on: May 22, 2024